118.97
0.42%
-0.50
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SRPT?
Forum
Prognose
Aktiensplit
Finanzdaten der Sarepta Therapeutics Inc-Aktie (SRPT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
4.20%
413.46
|
396.78 | 331.82 | 261.24 | 253.50 |
Operating Expenses
|
1.72%
378.56
|
372.16 | 352.66 | 394.76 | 391.59 |
Interest Income/Expense |
20.41%
4.166
|
5.234 | 5.229 | 5.224 | 6.323 |
Benefits Costs and Expenses |
4.38%
372.02
|
356.41 | 364.99 | 275.82 | 766.21 |
Costs And Expenses |
1.72%
378.56
|
372.16 | 352.66 | 394.76 | 391.59 |
Operating Income/Loss |
41.75%
34.91
|
24.62 | -20.84 | -133.52 | -138.09 |
Nonoperating Income/Loss |
58.45%
6.543
|
15.75 | -12.33 | 118.93 | -374.62 |
Income/Loss From Continuing Operations Before Tax |
2.67%
41.45
|
40.37 | -33.17 | -14.59 | -512.71 |
Income Tax Expense/Benefit |
200.85%
5.329
|
-5.284 | 7.763 | 9.355 | 4.045 |
Income/Loss From Continuing Operations After Tax |
20.89%
36.12
|
45.66 | -40.94 | -23.94 | -516.75 |
Net Income/Loss
|
20.89%
36.12
|
45.66 | -40.94 | -23.94 | -516.75 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,381%
93.99
|
3.789 | 88.89 | 88.74 | 88.19 |
Diluted Average Shares |
2,516%
99.11
|
3.789 | 88.89 | 88.74 | 88.19 |
Basic Earnings Per Share |
50.00%
0.38
|
0.76 | -0.46 | -0.27 | -5.86 |
Diluted Earnings Per Share |
51.32%
0.37
|
0.76 | -0.46 | -0.27 | -5.86 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):